HU9201929D0 - Process for the production of imidazo-diazepines - Google Patents
Process for the production of imidazo-diazepinesInfo
- Publication number
- HU9201929D0 HU9201929D0 HU9201929A HU9201929A HU9201929D0 HU 9201929 D0 HU9201929 D0 HU 9201929D0 HU 9201929 A HU9201929 A HU 9201929A HU 9201929 A HU9201929 A HU 9201929A HU 9201929 D0 HU9201929 D0 HU 9201929D0
- Authority
- HU
- Hungary
- Prior art keywords
- diazepines
- imidazo
- production
- Prior art date
Links
- BMGXAZCDDYTVFV-UHFFFAOYSA-N imidazo[4,5-c]diazepine Chemical class C1=CN=NC2=NC=NC2=C1 BMGXAZCDDYTVFV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH179191 | 1991-06-17 | ||
| CH114092 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU9201929D0 true HU9201929D0 (en) | 1992-08-28 |
Family
ID=25686778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9201929A HU9201929D0 (en) | 1991-06-17 | 1992-06-10 | Process for the production of imidazo-diazepines |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5387585A (OSRAM) |
| EP (1) | EP0519307A3 (OSRAM) |
| JP (1) | JPH078869B2 (OSRAM) |
| KR (1) | KR930000517A (OSRAM) |
| AU (1) | AU655472B2 (OSRAM) |
| CA (1) | CA2069382A1 (OSRAM) |
| CZ (1) | CZ185092A3 (OSRAM) |
| FI (1) | FI922827A7 (OSRAM) |
| HU (1) | HU9201929D0 (OSRAM) |
| IE (1) | IE921945A1 (OSRAM) |
| IL (1) | IL102175A0 (OSRAM) |
| IS (1) | IS3878A (OSRAM) |
| NO (1) | NO922367L (OSRAM) |
| NZ (1) | NZ243091A (OSRAM) |
| TW (1) | TW201311B (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW349100B (en) * | 1994-11-11 | 1999-01-01 | Hoffmann La Roche | Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines |
| JPH10298078A (ja) * | 1997-05-06 | 1998-11-10 | Mitsubishi Chem Corp | 抗不安薬 |
| TWI239333B (en) | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
| US6686352B2 (en) * | 2001-05-18 | 2004-02-03 | Hoffmann-La Roche Inc. | Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives |
| IL159320A0 (en) * | 2001-06-12 | 2004-06-01 | Wellstat Therapeutics Corp | Compounds for the treatment of metabolic disorders |
| CN101039678B (zh) * | 2004-10-12 | 2011-06-15 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗认知障碍的咪唑并[1,5-a]三唑并[1,5-d]苯并二氮杂䓬衍生物 |
| NZ554556A (en) * | 2004-10-20 | 2009-11-27 | Hoffmann La Roche | Halogen substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepines |
| EP1805184B1 (en) * | 2004-10-20 | 2013-01-09 | F. Hoffmann-La Roche AG | Imidazo-benzodiazepine derivatives |
| ATE396998T1 (de) * | 2004-12-14 | 2008-06-15 | Hoffmann La Roche | Tetrazyklische imidazobenzodiazepine als gaba- rezeptormodulatoren |
| CN101287738B (zh) * | 2005-10-11 | 2011-08-10 | 弗·哈夫曼-拉罗切有限公司 | 咪唑并苯并二氮杂*衍生物 |
| US9322831B2 (en) | 2008-09-23 | 2016-04-26 | The Johns Hopkins University | DDX3 as a biomarker for cancer and methods related thereto |
| AU2009300357B2 (en) * | 2008-09-23 | 2014-07-03 | The Johns Hopkins University | Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| AU2014240289B2 (en) * | 2008-09-23 | 2015-12-03 | The Johns Hopkins University | Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| BR112013012062B1 (pt) | 2010-11-15 | 2020-06-02 | Agenebio, Inc | Composto derivado da piridazina ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso do composto |
| DK3363790T3 (da) | 2013-09-06 | 2020-04-27 | Aurigene Discovery Tech Ltd | 1,2,4-oxadiazolderivater som immunmodulatorer |
| NZ722077A (en) | 2013-12-20 | 2021-12-24 | Agenebio Inc | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| SG11201706902SA (en) * | 2015-03-10 | 2017-09-28 | Aurigene Discovery Tech Ltd | 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators |
| CU24509B1 (es) | 2015-03-10 | 2021-05-12 | Aurigene Discovery Tech Ltd | Compuestos de 1,2,4-oxadiazol y tiadiazol como inmunomoduladores |
| CN108026107B (zh) | 2015-06-19 | 2021-07-30 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法 |
| AU2016378723B2 (en) | 2015-12-22 | 2021-09-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
| US20180170941A1 (en) * | 2016-12-19 | 2018-06-21 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
| MA49458A (fr) | 2017-06-21 | 2020-04-29 | SHY Therapeutics LLC | Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques |
| WO2019061324A1 (en) | 2017-09-29 | 2019-04-04 | Curis Inc. | CRYSTALLINE FORMS OF IMMUNOMODULATORS |
| KR20240151258A (ko) | 2017-10-11 | 2024-10-17 | 오리진 온콜로지 리미티드 | 3-치환된 1,2,4-옥사다이아졸의 결정질 형태 |
| EA202090746A1 (ru) | 2017-11-03 | 2020-08-17 | Ориджен Дискавери Текнолоджис Лимитед | Двойные ингибиторы путей tim-3 и pd-1 |
| CN111386128A (zh) | 2017-11-06 | 2020-07-07 | 奥瑞基尼探索技术有限公司 | 用于免疫调节的联合疗法 |
| IL279530B1 (en) | 2018-06-19 | 2025-09-01 | Agenebio Inc | Benzodiazepine history, preparations, and methods for treating cognitive disorder |
| EP3898609A1 (en) | 2018-12-19 | 2021-10-27 | Shy Therapeutics LLC | Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1143728A (en) * | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| NZ210850A (en) * | 1984-01-19 | 1988-10-28 | Hoffmann La Roche | Imidazodiazepine derivatives and pharmaceutical compositions |
| US4897392A (en) * | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| DK443589D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
| DK41191D0 (da) * | 1991-03-07 | 1991-03-07 | Novo Nordisk As | Heterocycliske forbindelser, deres fremstilling og anvendelse |
-
1992
- 1992-05-15 TW TW081103807A patent/TW201311B/zh active
- 1992-05-25 CA CA002069382A patent/CA2069382A1/en not_active Abandoned
- 1992-06-10 NZ NZ243091A patent/NZ243091A/en unknown
- 1992-06-10 EP EP19920109745 patent/EP0519307A3/de not_active Withdrawn
- 1992-06-10 HU HU9201929A patent/HU9201929D0/hu unknown
- 1992-06-11 IL IL102175A patent/IL102175A0/xx unknown
- 1992-06-12 AU AU18234/92A patent/AU655472B2/en not_active Ceased
- 1992-06-12 JP JP4179406A patent/JPH078869B2/ja not_active Expired - Lifetime
- 1992-06-12 IS IS3878A patent/IS3878A/is unknown
- 1992-06-16 CZ CS921850A patent/CZ185092A3/cs unknown
- 1992-06-16 NO NO92922367A patent/NO922367L/no unknown
- 1992-06-16 KR KR1019920010394A patent/KR930000517A/ko not_active Withdrawn
- 1992-06-17 FI FI922827A patent/FI922827A7/fi not_active Application Discontinuation
- 1992-07-01 IE IE194592A patent/IE921945A1/en not_active Application Discontinuation
-
1993
- 1993-11-15 US US08/153,234 patent/US5387585A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI922827A0 (fi) | 1992-06-17 |
| IL102175A0 (en) | 1993-01-14 |
| US5387585A (en) | 1995-02-07 |
| NO922367D0 (no) | 1992-06-16 |
| AU655472B2 (en) | 1994-12-22 |
| IS3878A (is) | 1992-12-18 |
| EP0519307A2 (de) | 1992-12-23 |
| IE921945A1 (en) | 1992-12-30 |
| TW201311B (OSRAM) | 1993-03-01 |
| JPH05202051A (ja) | 1993-08-10 |
| FI922827A7 (fi) | 1992-12-18 |
| EP0519307A3 (en) | 1993-04-21 |
| CZ185092A3 (en) | 1993-12-15 |
| NZ243091A (en) | 1994-11-25 |
| CA2069382A1 (en) | 1992-12-18 |
| NO922367L (no) | 1992-12-18 |
| AU1823492A (en) | 1992-12-24 |
| JPH078869B2 (ja) | 1995-02-01 |
| KR930000517A (ko) | 1993-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9200392D0 (en) | Process for the production of new beta-amino-alpha-hydroxycarboxyl-acid | |
| HU9201929D0 (en) | Process for the production of imidazo-diazepines | |
| HU913595D0 (en) | Process for the production of tnf-muteines | |
| HU913664D0 (en) | Process for the production of indian- and kinoline derivatives | |
| HU912005D0 (en) | Process for the production of aminobenzodiazepines | |
| HU913290D0 (en) | Process for the production of cyuclodextrines | |
| HU910151D0 (en) | Process for the production of substituted 2-chloride-pyridines | |
| HU9200933D0 (en) | Process for the production of kinoline derivatives | |
| HUT64763A (en) | Process for the production of cyclobutane-purines | |
| SG47726A1 (en) | Process for the manufacture of 2-alkoxymethylacrolein | |
| HU913280D0 (en) | Process for the production of 8-chloro-kinoline derivatives | |
| HU910937D0 (en) | Process for the production of 8-sulfamylethylene-2-amino-tetraline derivatives | |
| HU9201260D0 (en) | Process for the production of new indole- and dihydrokinoline derivatives | |
| HUT65728A (en) | Improved process for the production of glycosil-transpherases | |
| HU9200117D0 (en) | Process for the production of 3'-fluor-pirimidine nucleozides | |
| IL100132A0 (en) | Process for the production of decabromodiphenylalkane | |
| EP0510391A3 (en) | Process for the production of polyphenylenethers | |
| HU912132D0 (en) | Process for the production of 16-methylene-17-hydroxy-19-norprogesterone | |
| HU9201054D0 (en) | Process for the production of alkenyl-alkanoate-catalysts | |
| HU9201095D0 (en) | Process for the production of sulphonyl-carbamides | |
| HU911990D0 (en) | Process for the production of acyl-oxy-methane-sulphonates | |
| HU910107D0 (en) | Process for the production of fitohemagglutinin | |
| HU913554D0 (en) | Process for the production of aryl-sulphonyl-izocyanates | |
| HU914021D0 (en) | Process for the production of new tetrahydro-naphtaline-derivatives | |
| EP0534412A3 (en) | Process for the production of 4-chloro-trichloro-methyl benzene |